Strategic Initiative

Slingshot members are tracking this corporate initiative:

Novartis (NVS) Acquires Selexys for $665MM to Expand Portfolio for Blood Disorders

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Selexys Pharmaceuticals

Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Nov 21, 2016
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2019
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Acquisition, Blood Disorders, Blood Diseases, Inflammatory Disorders